 | PRD_002485 | Name: | [(2S,3R,4S,5S,6R)-6-(hydroxymethyl)-2,4,5-tris(oxidanyl)oxan-3-yl]oxy-N-[9-[(2R,3S,5R)-5-[[[(2R,3S)-4-methyl-2,3-bis(oxidanyl)pentanoyl]amino]-oxidanyl-phosphoryl]oxy-3-oxidanyl-oxolan-2-yl]purin-6-yl]phosphonamidic acid | Formula: | C21 H34 N6 O16 P2 | Description: | unusual glycan purine conjugate (containing GLC and ADE) | Definition date: | 2024-01-24 | Last modified: | 2024-01-24 |
|
 | PRD_000217 | Name: | Daptomycin | Formula: | C72 H101 N17 O26 | Description: |
DAPTOMYCIN IS AN ACIDIC CYCLIC LIPOPEPTIDE.
THE SCAFFOLD IS MADE OF TWO PARTS:
(1) THREE RESIDUES N-TERM EXOCYCLIC PART
(2) A DECAPEPTIDE LACTONE RING DERIVED FROM
CYCLISATION OF THR3 SIDE CHAIN ONTO THE C-TER
CARBOXYL GROUP
THE N-DECANOYL FATTY ACID IS LINKED TO THE
MAIN BODY OF THE MOLECULE VIA N-TERM ACYLATION. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000313 | Name: | MeOSuc-Ala-Ala-Pro-boroIle | Formula: | C21 H37 B N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_002484 | Name: | [(2R,3R,4S,5S,6R)-6-(hydroxymethyl)-2,4,5-tris(oxidanyl)oxan-3-yl]oxy-N-[9-[(2R,3S,5R)-5-[[[(2R,3S)-4-methyl-2,3-bis(oxidanyl)pentanoyl]amino]-oxidanyl-phosphoryl]oxy-3-oxidanyl-oxolan-2-yl]purin-6-yl]phosphonamidic acid | Formula: | C21 H34 N6 O16 P2 | Description: | unusual glycan purine conjugate (containing BGC and ADE) | Definition date: | 2023-06-14 | Last modified: | 2023-06-14 |
|
 | PRD_002393 | Name: | UAW247 | Formula: | C24 H27 N3 O5 | Definition date: | 2020-06-17 | Last modified: | 2020-06-17 |
|